Cytosorbents's total assets for Q3 2024 were $47.80M, a decrease of -10.52% from the previous quarter. CTSO total liabilities were $34.80M for the fiscal quarter, a -5.14% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.